As part of the agreement signed by the Republican Centre for Technology Transfer (RCTT) and the Middle East and North Africa Financial Network (MENAFN) on April 29, 2026, the following business offers of  the Unitary Enterprise "Pilot Production of the Institute of Bioorganic Chemistry of the NAS of Belarus", selected by MENAFN experts from the Catalogue of Innovation Offers by Organizations of the National Academy of Sciences of Belarus, have been posted on the MENAFN website:

• BO Rapid test for the detection of the nucleocapsid antigen of the SARS-CoV-2 virus and antigens of influenza A and B viruses by immunochromatographic analysis: Rapid test SARS CoV-2-Influenza-A/B-Antigen
• BO A set of ELISA-CA125 reagents for determining the concentration of tumor antigen CA125 in human serum
• BO Rapid test for the detection of IgM and IgG antibodies to the SARS-CoV-2 coronavirus in human blood, serum, and plasma using immunochromatographic analysis - Rapid test SARS CoV-2IgM/IgG
• BO Rapid test for the detection of the nucleocapsid antigen of the SARS-CoV-2 virus by immunochromatographic analysis: Rapid test SARS CoV-antigen
• BO Reagent kit for syphilis diagnostics (RPR test)
• BO The IRMA-TTG-ST kit for the quantitative determination of the concentration of thyroid stimulating hormone in human serum or plasma

All cooperation proposals from organizations of the NAS of Belarus, posted on the MENAFN website can be found here.